Cell Growth & Differentiation, Vol 9, Issue 2 139-146, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts

M Vogt, C Haggblom, J Yeargin, T Christiansen-Weber and M Haas
Molecular Biology and Virology Laboratory, Salk Institute, San Diego, California 92186-5800, USA.

In this work, we address the question of whether replicative senescence can be induced in immortal nontumorigenic human fibroblasts. The immortal fibroblasts used in this study were derived from two Li-Fraumeni (LF) patients who carry in their germ line one wild-type and one mutant p53 allele. Both immortal lines have lost the wtp53 allele and express no detectable p16INK4a protein, although they carry the p16INK4a gene. In contrast to immortal human fibroblasts, senescent human fibroblasts have a low content of 5-methyl-cytosine in their DNA. This observation suggested the possibility that a demethylating agent could revert the immortal phenotype and induce replicative senescence in the immortal cell lines. Cells of the two LF lines were exposed to the demethylating agent 5-aza-2'-deoxycytidine. Within 6 days, all cells were growth arrested and showed the enlarged and flat morphology characteristic of senescent cells, an accumulation of lipofuscin granules and senescence-associated beta-galactosidase activity at pH6, both biomarkers for senescence. Immunoblots of 5-aza-2'-deoxycytidine-treated cells showed a greatly increased expression of p16INK4a protein but no detectable change in the expression of p21CIP1, a gene known to be strongly expressed in senescent normal human fibroblasts. In two other experimental series, cells of the two LF lines were infected with retroviral constructs encoding either p16INK4a or p21CIP1. Each of the transduced genes induced senescence without affecting the expression of the other endogenous gene. The results show that induction of senescence in immortal LF fibroblasts can occur by different pathways: (a) by demethylation-dependent pathways that induce the expression of p16INK4a; and (b) by demethylation-independent pathways involving the expression of p21CIP1. The induction of senescence by p16INK4a and p21CIP1 occurred equally in the two human immortal fibroblast lines, which differed in the length of their telomeres and the activity of their telomerase.

This article has been cited by other articles:

				Q. Li, L. Tang, P. C. Roberts, J. M. Kraniak, A. L. Fridman, O. I. Kulaeva, O. S. Tehrani, and M. A. Tainsky Interferon Regulatory Factors IRF5 and IRF7 Inhibit Growth and Induce Senescence in Immortal Li-Fraumeni Fibroblasts Mol. Cancer Res., May 1, 2008; 6(5): 770 - 784. [Abstract] [Full Text] [PDF]

				N. Widodo, C. C. Deocaris, K. Kaur, K. Hasan, T. Yaguchi, K. Yamasaki, T. Sugihara, T. Ishii, R. Wadhwa, and S. C. Kaul Stress Chaperones, Mortalin, and Pex19p Mediate 5-Aza-2' Deoxycytidine-Induced Senescence of Cancer Cells by DNA Methylation-Independent Pathway J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 246 - 255. [Abstract] [Full Text] [PDF]

				A. L. Fridman, L. Tang, O. I. Kulaeva, B. Ye, Q. Li, F. Nahhas, P. C. Roberts, S. J. Land, J. Abrams, and M. A. Tainsky Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton. J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 879 - 889. [Abstract] [Full Text] [PDF]

				E. V. Sviderskaya, V. C. Gray-Schopfer, S. P. Hill, N. P. Smit, T. J. Evans-Whipp, J. Bond, L. Hill, V. Bataille, G. Peters, D. Kipling, et al. p16/Cyclin-Dependent Kinase Inhibitor 2A Deficiency in Human Melanocyte Senescence, Apoptosis, and Immortalization: Possible Implications for Melanoma Progression J Natl Cancer Inst, May 21, 2003; 95(10): 723 - 732. [Abstract] [Full Text] [PDF]

				T. Davis, S. K. Singhrao, F. S. Wyllie, M. F. Haughton, P. J. Smith, M. Wiltshire, D. Wynford-Thomas, C. J. Jones, R. G. A. Faragher, and D. Kipling Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms J. Cell Sci., April 1, 2003; 116(7): 1349 - 1357. [Abstract] [Full Text] [PDF]

				T. Tsutsui, S.-i. Kumakura, A. Yamamoto, H. Kanai, Y. Tamura, T. Kato, M. Anpo, H. Tahara, and J.C. Barrett Association of p16INK4a and pRb inactivation with immortalization of human cells Carcinogenesis, December 1, 2002; 23(12): 2111 - 2117. [Abstract] [Full Text] [PDF]

				Md. K. Hasan, T. Yaguchi, T. Sugihara, P. K. R. Kumar, K. Taira, R. R. Reddel, S. C. Kaul, and R. Wadhwa CARF Is a Novel Protein That Cooperates with Mouse p19ARF (Human p14ARF) in Activating p53 J. Biol. Chem., September 27, 2002; 277(40): 37765 - 37770. [Abstract] [Full Text] [PDF]

				R. Marcotte and E. Wang Replicative Senescence Revisited J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): B257 - 269. [Abstract] [Full Text]

				S. R. Schwarze, S. E. DePrimo, L. M. Grabert, V. X. Fu, J. D. Brooks, and D. F. Jarrard Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells J. Biol. Chem., April 19, 2002; 277(17): 14877 - 14883. [Abstract] [Full Text] [PDF]

				E. V. Sviderskaya, S. P. Hill, T. J. Evans-Whipp, L. Chin, S. J. Orlow, D. J. Easty, S. C. Cheong, D. Beach, R. A. DePinho, and D. C. Bennett p16Ink4a in Melanocyte Senescence and Differentiation J Natl Cancer Inst, March 20, 2002; 94(6): 446 - 454. [Abstract] [Full Text] [PDF]

				E. C. Goodwin and D. DiMaio Induced Senescence in HeLa Cervical Carcinoma Cells Containing Elevated Telomerase Activity and Extended Telomeres Cell Growth Differ., November 1, 2001; 12(11): 525 - 534. [Abstract] [Full Text] [PDF]

				D. L. Kramer, B.-D. Chang, Y. Chen, P. Diegelman, K. Alm, A. R. Black, I. B. Roninson, and C. W. Porter Polyamine Depletion in Human Melanoma Cells Leads to G1 Arrest Associated with Induction of p21WAF1/CIP1/SDI1, Changes in the Expression of p21-regulated Genes, and a Senescence-like Phenotype Cancer Res., November 1, 2001; 61(21): 7754 - 7762. [Abstract] [Full Text] [PDF]

				S. B. Baylin, M. Esteller, M. R. Rountree, K. E. Bachman, K. Schuebel, and J. G. Herman Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer Hum. Mol. Genet., April 1, 2001; 10(7): 687 - 692. [Abstract] [Full Text] [PDF]

				B.-D. Chang, K. Watanabe, E. V. Broude, J. Fang, J. C. Poole, T. V. Kalinichenko, and I. B. Roninson Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases PNAS, April 11, 2000; 97(8): 4291 - 4296. [Abstract] [Full Text] [PDF]

				R. R. Reddel The role of senescence and immortalization in carcinogenesis Carcinogenesis, March 1, 2000; 21(3): 477 - 484. [Abstract] [Full Text] [PDF]

				J. Kajstura, B. Pertoldi, A. Leri, C.-A. Beltrami, A. Deptala, Z. Darzynkiewicz, and P. Anversa Telomere Shortening Is an in Vivo Marker of Myocyte Replication and Aging Am. J. Pathol., March 1, 2000; 156(3): 813 - 819. [Abstract] [Full Text] [PDF]

				W. R. Taylor, S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schönthal, K. S. Katula, and G. R. Stark Mechanisms of G2 Arrest in Response to Overexpression of p53 Mol. Biol. Cell, November 1, 1999; 10(11): 3607 - 3622. [Abstract] [Full Text]

				B.-D. Chang, E. V. Broude, M. Dokmanovic, H. Zhu, A. Ruth, Y. Xuan, E. S. Kandel, E. Lausch, K. Christov, and I. B. Roninson A Senescence-like Phenotype Distinguishes Tumor Cells That Undergo Terminal Proliferation Arrest after Exposure to Anticancer Agents Cancer Res., August 1, 1999; 59(15): 3761 - 3767. [Abstract] [Full Text] [PDF]

				L. I. Huschtscha and R. R. Reddel p16INK4a and the control of cellular proliferative life span Carcinogenesis, June 1, 1999; 20(6): 921 - 926. [Abstract] [Full Text] [PDF]

				J. A. Bond, M. F. Haughton, J. M. Rowson, P. J. Smith, V. Gire, D. Wynford-Thomas, and F. S. Wyllie Control of Replicative Life Span in Human Cells: Barriers to Clonal Expansion Intermediate Between M1 Senescence and M2 Crisis Mol. Cell. Biol., April 1, 1999; 19(4): 3103 - 3114. [Abstract] [Full Text] [PDF]

				B. B. McConnell, F. J. Gregory, F. J. Stott, E. Hara, and G. Peters Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes Mol. Cell. Biol., March 1, 1999; 19(3): 1981 - 1989. [Abstract] [Full Text] [PDF]

				L. E. Lantry, Z. Zhang, K. A. Crist, Y. Wang, G. J. Kelloff, R. A. Lubet, and M. You 5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model Carcinogenesis, February 1, 1999; 20(2): 343 - 346. [Abstract] [Full Text] [PDF]

				A. W. Lin, M. Barradas, J. C. Stone, L. van Aelst, M. Serrano, and S. W. Lowe Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling Genes & Dev., October 1, 1998; 12(19): 3008 - 3019. [Abstract] [Full Text]

				J. M. Sedivy Can ends justify the means?: Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells PNAS, August 4, 1998; 95(16): 9078 - 9081. [Abstract] [Full Text] [PDF]

				T. Sugihara, S. C. Kaul, J.-y. Kato, R. R. Reddel, H. Nomura, and R. Wadhwa Pex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway* J. Biol. Chem., May 25, 2001; 276(22): 18649 - 18652. [Abstract] [Full Text] [PDF]

				M. Collado, R. H. Medema, I. Garcia-Cao, M. L. N. Dubuisson, M. Barradas, J. Glassford, C. Rivas, B. M. T. Burgering, M. Serrano, and E. W.-F. Lam Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1 J. Biol. Chem., July 14, 2000; 275(29): 21960 - 21968. [Abstract] [Full Text] [PDF]